Cascara Sagrada (Frangula purshiana): Uses, Evidence and Safety
Cascara sagrada (Frangula purshiana, also named Rhamnus purshiana) is a bark used as a stimulant laxative: what the EU committee and US FDA say, and limits on use, potassium and pregnancy.
Content last updated . This page has not been medically reviewed.

Safety first. Supplements can cause side effects and interact with medicines. Read mushroom safety and interactions before you use any mushroom product.
What is Cascara sagrada good for?
What the body uses it for, and how strong the evidence is. A normal job in the body is not proof that extra supplements add benefit; each card says which.
Short-term relief of occasional constipation
Clinically supportedCascara bark is taken for occasional constipation. The EU herbal committee accepts this use for up to one week.
Supplements: Accepted by a regulator on long-standing use; no trials of cascara on its own were found by the committee.
Stimulant effect on the bowel
Clinically supportedIts active compounds (anthraquinones, comparable to those in senna) make the bowel move and soften stool.
Supplements: Describes how it works, not extra benefit.
Weight loss or body cleansing
Not enough evidenceNo source read supports cascara for weight loss or cleansing; laxative misuse is a concern in eating disorders.
Supplements: No evidence of benefit found.
Connected topics
Open a group to see how each topic connects and how strong the evidence is.
Health goals (1)
- Digestive SupportClinically supported
The EU herbal committee accepts cascara bark for short-term treatment of occasional constipation, based on long-standing use. It has not been tested on its own in trials, and it is not for regular use.
Body systems (2)
- Digestive SystemClinically supported
Used short term for occasional constipation (EU regulator view, based on well-established use rather than cascara-specific trials).
- Gut HealthClinically supported
Its anthraquinones stimulate bowel movements and change water and salt absorption in the gut, which softens stool. Short-term use only.
Body parts (1)
- GutClinically supported
Acts on the bowel to stimulate movement and soften stool; used for occasional constipation only.
Functional actions (1)
- Digestive SupportClinically supported
A stimulant laxative: it prompts bowel movements. Not meant for more than one week; long-term use can cause problems.
Root causes (2)
- DehydrationDocumented risk
Diarrhoea and fluid and salt imbalance can follow use, especially long term; severe dehydration is a listed reason not to use it.
- Digestive DysfunctionClinically supported
Occasional constipation is the one use accepted by the EU committee; persistent constipation needs a doctor.
Conditions & symptoms (4)
- ConstipationClinically supported
Accepted for short-term treatment of occasional constipation; not for persistent constipation or long-term use.
- DehydrationDocumented risk
Severe dehydration is a listed reason not to use cascara, and fluid loss can follow use.
- DiarrheaDocumented risk
Diarrhoea and belly pain are listed side effects.
- Water-Electrolyte ImbalanceDocumented risk
Fluid and salt imbalance can occur with long-term use.
Documented risks and interactions (6)
- Dependence and bowel function with long-term use. Using stimulant laxatives for a long time may lead to the bowel not working properly and reliance on laxatives. Use no longer than one week.
- Fluid and salt imbalance, diarrhoea and belly pain. Possible side effects are belly pain, spasm, diarrhoea and, with long use, fluid and salt imbalance.
- Darkened bowel lining and urine changes. Long-term use may darken the lining of the bowel, and cause protein or blood in the urine and yellow or red-brown urine.
- Not for pregnancy, breastfeeding or children under 12. The EU committee says cascara must not be used in pregnancy, while breastfeeding, or by children under 12.
- Bowel conditions and dehydration where it should not be used. Not for bowel blockage or narrowing, appendicitis, inflammatory bowel disease, unexplained belly pain or severe dehydration.
- Allergic reactions. Itching or rash can occur; allergy to the preparation is a reason not to use it.
Safety first: cascara is a stimulant laxative for short-term use only. The EU herbal committee (HMPC) says cascara preparations are for the short-term treatment of occasional constipation, should not be taken for more than one week, and must not be used in pregnancy, while breastfeeding or by children under 12. [1] Long-term use may lead to the bowels not working properly and to dependence on laxatives. [1] In the US, FDA's over-the-counter drug rule lists cascara sagrada ingredients among laxative ingredients for which there are "inadequate data to establish general recognition of the safety and effectiveness." [2] Laxative misuse is also a feature of some eating disorders; see eating disorders, weight-loss supplements and laxative misuse. In the US, call or text 988 in a crisis.
What cascara is
Cascara is the bark of the tree the EU committee names Rhamnus purshiana DC. [1] GBIF's accepted name is Frangula purshiana (DC.) J.G.Cooper, family Rhamnaceae, so the two names refer to the same plant in these sources. [3] It contains anthraquinones, compounds comparable to those in other herbal laxatives such as senna. [1] See the senna profile and herbs for constipation.Traditional use
Proper evidence not found: the sources we read do not describe the traditional use of cascara by a named people or region, so we do not describe it. The EU committee's conclusion rests on "well-established use" in occasional constipation, meaning bibliographic data on effectiveness and safety covering at least 10 years in the EU. [1]What research and official bodies say
| Question | What the source found | Strength of evidence | Form studied |
|---|---|---|---|
| Does cascara relieve occasional constipation? | The EU committee concluded it can be used short term. [1] It also says there are no studies evaluating cascara alone or with other laxatives, so its view rests on clinical experience, on how the medicine works, and on studies of other anthraquinone-containing substances. [1] | Established use (regulator), but Proper evidence not found for cascara-specific trials | Standardized bark preparations |
| Cascara in a trial | One 2004 Korean trial randomized 34 people with functional constipation to placebo, ear mushroom fiber, or ear mushroom with additives including cascara sagrada. [4] The combination cannot show what cascara alone does. | Insufficient evidence | Mixed product; 34 people |
| Weight loss, "cleansing" | Proper evidence not found in the sources we read (EU summary and monograph, FDA rule, PubMed abstracts). | No good evidence of benefit | Not applicable |
Forms
The EU committee's conclusions cover dried, cut bark and liquid or dry extracts made with water or ethanol, standardized to a defined anthraquinone amount; products are usually herbal tea or solid and liquid forms. [1] Tea, tablet and extract are not interchangeable. See senna and other laxative teas. We give no amounts for a reader.Safety
- Duration and dependence: the EU monograph says long-term use of stimulant laxatives should be avoided, and cascara should be used only if diet change or bulk-forming agents fail. [5]
- Side effects: allergic reactions, belly pain and spasm, diarrhea, darkened bowel lining that usually recovers after stopping, water and salt imbalance, and protein or blood in the urine with long use. [1][5]
- Potassium and medicines: use with diuretics, corticosteroids and licorice root may increase potassium loss; people taking heart glycosides, antiarrhythmics or QT-prolonging medicines must consult a doctor. [5] See how interactions work.
- Pregnancy and breastfeeding: contraindicated, citing experimental data on genotoxic risk of related compounds and small amounts of an active metabolite found in breast milk. [5] See pregnancy and breastfeeding.
- Children: under 12, not to be used. [1]
- Liver: the monograph says chronic overdoses of anthranoid-containing medicines may lead to toxic hepatitis. [5]
- Kidney: people with kidney disorders should be aware of possible electrolyte imbalance. [5]
- Eating disorders: the NHS lists taking laxatives among purging behaviors in bulimia and warns of physical problems from overusing them. [6]
- Surgery, allergy: hypersensitivity is a listed contraindication. [5] Surgery is not described in the sources we read; tell the surgical team (guide).
Frequently asked questions
How long can cascara be used?
The EU committee says not more than one week. [1]
Is cascara sagrada approved by FDA as a laxative?
FDA's rule lists cascara sagrada ingredients among OTC laxative ingredients with inadequate data on safety and effectiveness. [2] Ask a pharmacist about current products.
Is cascara safe in pregnancy?
The EU committee says it must not be used in pregnancy or breastfeeding. [1]
What are the main risks of long-term use?
Dependence, imbalance of water and salts (including potassium), and in overdose, toxic hepatitis. [1][5]
Does cascara cause weight loss?
Proper evidence not found; the sources we read describe it only for constipation.
References
- European Medicines Agency (EMA, EU), Rhamni purshianae cortex (cascara): herbal medicinal product, summary of HMPC conclusions, summary for the public first published 2020. Read 2026-10-23.
- US Food and Drug Administration, 21 CFR 310.545 (a)(12), Drug products containing certain active ingredients offered over-the-counter for certain uses, electronic Code of Federal Regulations. Read 2026-10-23.
- GBIF Backbone Taxonomy, Frangula purshiana match record. Read 2026-10-23.
- Kim TI, Park SJ, Choi CH, et al. Effect of ear mushroom (Auricularia) on functional constipation (Korean). Korean J Gastroenterol. 2004. Read 2026-10-23.
- EMA, HMPC, European Union herbal monograph on Rhamnus purshiana DC., cortex, Revision 1 (EMA/HMPC/726270/2016), 6 May 2020. Read 2026-10-23.
- National Health Service (NHS, UK), Bulimia. Read 2026-10-23.